SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ProFibrix Passes Halfway Mark of Patient Enrolment in Pivotal Phase 3 With Fibrocaps™ and Successfully Concludes Safety Review Assessment